pyrazines has been researched along with lgk974 in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 24 (64.86) | 24.3611 |
2020's | 13 (35.14) | 2.80 |
Authors | Studies |
---|---|
Boral, AL; Brenner, JC; Carey, TE; Che, J; Cheng, D; Cheng, J; Flynn, S; Graham, MP; Guo, G; Harris, JL; Hsieh, MH; Kasibhatla, S; Kowal, C; Li, AG; Li, C; Li, J; Liu, J; McLaughlin, ME; McNamara, P; Ng, N; Pan, S; Petruzzelli, L; Pferdekamper, A; Phung, V; Schuller, AG; Schultz, PG; Seidel, HM; Sellers, WR; Steffy, A; Sun, F; Tompkins, C; Vanasse, G; Villarroel, MC; Wang, T; Wang, Y; Wu, X | 1 |
Chen, K; Gaur, S; Hu, S; Liu, YR; Pan, SL; Tzeng, HE; Wang, Y; Yang, L; Yen, Y | 1 |
Eberhart, CG; Hayashi, M; Kahlert, UD; Koch, K; Maciaczyk, J; Natsumeda, M; Orr, BA; Suwala, AK | 1 |
Dong, Y; He, S; Hu, Z; Li, J; Li, K; Luo, L; Ma, H; Sun, Z; Wu, Y; Xu, Z; Zhang, H; Zhang, X; Zheng, J | 1 |
Baryawno, N; Calero, R; Darabi, A; Dyberg, C; Einvik, C; Johnsen, JI; Kogner, P; Kool, M; Milosevic, J; Sandén, E; Siesjö, P; Sveinbjörnsson, B; Wickström, M | 1 |
Balk, SP; Cai, C; Chen, S; Gerrin, SJ; He, HH; He, L; Ma, F; Sowalsky, AG; Tanenbaum, BA; Wang, H; Ye, H; Yuan, X | 1 |
Lum, L; Zhang, LS | 2 |
Acquaviva, A; Bardelli, A; Centonze, A; Crisafulli, G; Medico, E; Novara, L; Petti, C; Picco, G; Torchiaro, E | 1 |
Jang, J; Jho, EH; Jung, Y; Kim, Y; Yoon, Y | 1 |
Amatruda, JF; Bao, X; Bassel-Duby, R; Feng, JQ; Liu, Y; Lum, L; Moon, J; Morlock, LK; Olson, EN; Palecek, SP; Tan, W; Williams, NS; Zhang, LS; Zhang, S; Zhou, H | 1 |
Chen, D; Fan, F; Liu, Q; Shi, Y; Tian, D | 1 |
Dow, LE; Elemento, O; Han, T; Murphy, C; Schatoff, EM; Wilkinson, JE; Zafra, MP | 1 |
Fan, S; Li, A; Li, Y; Liang, C; Meng, J; Shen, X; Wu, D; Wu, G; Xiao, Q; Xu, Y; Zhang, L; Zhang, X | 1 |
Bruens, L; Cammareri, P; Campbell, AD; Faller, WJ; Gay, DM; Hodder, MC; Huels, DJ; McLaughlin, ME; Morrissey, E; Nixon, C; Ridgway, RA; Sansom, OJ; Snippert, HJ; Solar-Abboud, M; van Rheenen, J; Winton, DJ; Zeiger, LB | 1 |
Basler, K; Cantù, C; Cecconi, V; Hafner, J; Hausmann, G; Restivo, G; Valenta, T; van den Broek, M; Zimmerli, D | 1 |
Brommage, R; Cohen-Solal, M; Funck-Brentano, T; Henning, P; Koskela, A; Lerner, UH; Movérare-Skrtic, S; Nilsson, KH; Ohlsson, C; Tuukkanen, J | 1 |
Cheng, JJ; Chiou, CT; Huang, CL; Huang, HM; Huang, HT; Huang, NK; Lee, YC; Yang, JM; Yang, YC | 1 |
Chung, A; Guimaraes, PPG; Jacks, T; Langer, R; Mitchell, MJ; Oberli, M; Riley, RS; Spektor, R; Tammela, T; Tan, M; Viana, CTR; Wang, K; Wu, K | 1 |
Gong, JP; Hu, H; Hu, YB; Li, XL; Mi, YL; Mu, L; Qin, JC; Tao, DD; Wu, YQ; Yan, C; Zhao, H | 1 |
Fang, J; Hao, J; Li, Z; Lian, X; Qin, T; Wu, H; Wu, J; Wu, S; Zhang, W; Zhou, Q | 1 |
Resham, K; Sharma, SS | 2 |
Bagheri, M; Ghasemi, F; Mirzaei, H; Tabatabae Far, MA | 1 |
Chen, H; Fang, J; Jiang, S; Ruan, Q; Sun, J; Yang, X; Zhang, M; Zhang, Y; Zhou, F; Zhou, W; Zhu, T | 1 |
Chen, Y; Li, J; Ruan, N; Wu, G; Xia, Q; Xu, Y; Zhang, Q | 1 |
Chen, S; Liu, S; Wen, F; Xu, H; Yi, M; Yuan, X | 1 |
Ang, GCK; Chang, KT; Guccione, E; Hebrard, M; Lee, VK; Leung, JY; Lim, HJ; Pal, A; Pignata, L; Rao, VK; Taneja, R | 1 |
Panchal, S; Patel, B; Shah, K | 1 |
Jang, J; Jho, EH; Kwon, YV; Lee, H; Sim, I; Song, J; Yoon, Y | 1 |
Albany, C; Chovanec, M; Cierna, Z; Kalavska, K; Konig, H; Kucerova, L; Liskova, V; Matuskova, M; Mego, M; Miklikova, S; Plava, J; Rogozea, A; Rojikova, L; Schmidtova, S | 1 |
Argilés, G; Connolly, RM; de Jonge, M; Dobson, JR; Garralda, E; Giannakis, M; Janku, F; Ji, Y; McLaughlin, ME; Moody, SE; Morawiak, J; Rodon, J; Seroutou, A; Smith, DC; Vaishampayan, U | 1 |
Arasaki, A; Kawabata-Iwakawa, R; Kina, S; Kinjo, T; Miyamoto, S; Sunakawa, H | 1 |
Bian, Z; Chen, M; Gong, RH; Huang, C; Kwan, HY; Wong, HLX | 1 |
Darabi, M; Hosseini, V; Kalantary-Charvadeh, A; Mehdizadeh, A; Nazari Soltan Ahmad, S; Nouri, M; Nozad Charoudeh, H; Rahbarghazi, R | 1 |
Huang, PH; Ji, Y; Myers, A; Woolfenden, S | 1 |
Donnelly, L; Elghobashi-Meinhardt, N; Li, X; Liu, Y; Long, T; Qi, X; Sun, Y; Wang, B; Zhou, RW | 1 |
2 review(s) available for pyrazines and lgk974
Article | Year |
---|---|
Chemical Modulation of WNT Signaling in Cancer.
Topics: Acyltransferases; Humans; Membrane Proteins; Neoplasms; Pyrazines; Pyridines; Wnt Proteins; Wnt Signaling Pathway | 2018 |
Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
Topics: Acyltransferases; Animals; Antineoplastic Agents; Drug Development; Drug Discovery; Enzyme Inhibitors; Humans; Membrane Proteins; Molecular Targeted Therapy; Neoplasms; Pyrazines; Pyridines; Wnt Signaling Pathway | 2021 |
1 trial(s) available for pyrazines and lgk974
Article | Year |
---|---|
Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours.
Topics: Administration, Oral; Adult; Aged; Axin Protein; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Neoplasms; Pyrazines; Pyridines; Treatment Outcome; Wnt Signaling Pathway | 2021 |
34 other study(ies) available for pyrazines and lgk974
Article | Year |
---|---|
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974.
Topics: Acyltransferases; Animals; Axin Protein; Blotting, Western; Cell Line, Tumor; Cloning, Molecular; High-Throughput Screening Assays; Humans; Membrane Proteins; Mice; Mutagenesis; Neoplasms; Phosphorylation; Pyrazines; Pyridines; Radioligand Assay; Rats; Receptors, Notch; Reverse Transcriptase Polymerase Chain Reaction; Wnt Signaling Pathway | 2013 |
The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
Topics: Animals; Apoptosis; beta Catenin; Blotting, Western; Cell Proliferation; Drug Resistance, Neoplasm; Female; Fluorescent Antibody Technique; Humans; Indazoles; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazines; Pyridines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; TOR Serine-Threonine Kinases; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Wnt Proteins; Xenograft Model Antitumor Assays | 2015 |
Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.
Topics: Adult; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Child; Glioblastoma; Humans; Pyrazines; Pyridines; Tumor Stem Cell Assay; Wnt Signaling Pathway | 2015 |
Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors.
Topics: Acyltransferases; Animals; Cytochrome P-450 CYP3A; Drug Design; Genes, Reporter; HEK293 Cells; Humans; Membrane Proteins; Microsomes, Liver; Pyrazines; Pyridines; Rats; Structure-Activity Relationship; Wnt Signaling Pathway | 2015 |
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Topics: Animals; Antineoplastic Agents; Benzeneacetamides; beta Catenin; Brain Neoplasms; Camptothecin; Celecoxib; Cisplatin; Colorectal Neoplasms; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; Glucose-6-Phosphate Isomerase; Heterocyclic Compounds, 3-Ring; Humans; Immunoblotting; Immunohistochemistry; Irinotecan; Medulloblastoma; Mice; Neoplasm Transplantation; Neoplasms; Neuroblastoma; Pyrans; Pyrazines; Pyridines; Real-Time Polymerase Chain Reaction; Sulfones; Temozolomide; Triazoles; Tumor Suppressor Proteins; Vincristine; Wnt Proteins; Wnt Signaling Pathway | 2015 |
SOX9 drives WNT pathway activation in prostate cancer.
Topics: Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Mice, SCID; Neoplasm Proteins; Prostatic Neoplasms; Pyrazines; Pyridines; SOX9 Transcription Factor; Transcription Factor 4; Transcription Factors; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
Delivery of the Porcupine Inhibitor WNT974 in Mice.
Topics: Acyltransferases; Animals; Membrane Proteins; Mice; Molecular Biology; Pyrazines; Pyridines; Wnt Proteins; Wnt Signaling Pathway | 2016 |
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
Topics: Axin Protein; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Resistance; Enzyme Inhibitors; Gene Fusion; Humans; Pyrazines; Pyridines; Thrombospondins; Wnt Proteins; Wnt Signaling Pathway | 2017 |
LPS-induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974.
Topics: Anti-Inflammatory Agents; Cell Line; Cytokines; Epithelial Cells; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Inflammation; Inflammation Mediators; Intercellular Signaling Peptides and Proteins; Lipopolysaccharides; NF-kappa B; Protein Binding; Pyrazines; Pyridines; Wnt Proteins; Wnt Signaling Pathway | 2017 |
Blockade to pathological remodeling of infarcted heart tissue using a porcupine antagonist.
Topics: Acyltransferases; Animals; Atrial Remodeling; Cells, Cultured; Collagen Type VI; Enzyme Inhibitors; Gene Expression; HEK293 Cells; Humans; Membrane Proteins; Mice, Inbred C57BL; Molecular Structure; Myocardial Infarction; Pyrazines; Pyridines; Regeneration; Wnt Signaling Pathway | 2017 |
The Wnt inhibitor LGK-974 enhances radiosensitivity of HepG2 cells by modulating Nrf2 signaling.
Topics: Acyltransferases; Apoptosis; Endoplasmic Reticulum; Hep G2 Cells; Humans; Liver Neoplasms; Membrane Proteins; NF-E2-Related Factor 2; Pyrazines; Pyridines; Radiation Tolerance; Reactive Oxygen Species; Signal Transduction; Wnt Signaling Pathway; Wnt3A Protein | 2017 |
R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine.
Topics: Acyltransferases; Animals; Chromosome Aberrations; Chromosomes; Colonic Neoplasms; Female; Gene Rearrangement; Humans; Intestines; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Pyrazines; Pyridines; Receptor-Like Protein Tyrosine Phosphatases, Class 2; Thrombospondins; Wnt Proteins | 2017 |
Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.
Topics: Animals; beta Catenin; Disease Models, Animal; Female; Heterocyclic Compounds, 3-Ring; Humans; Injections, Intraperitoneal; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Polycystic Kidney, Autosomal Dominant; Pyrazines; Pyridines; Random Allocation; Survival Analysis; Treatment Outcome; TRPP Cation Channels; Wnt Signaling Pathway | 2018 |
Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells.
Topics: Acyltransferases; Adenoma; Adenomatous Polyposis Coli Protein; Animals; Carcinogenesis; Cell Transformation, Neoplastic; Colorectal Neoplasms; Enzyme Inhibitors; Intestinal Mucosa; Ligands; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrazines; Pyridines; Stem Cells; Wnt Signaling Pathway | 2018 |
WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma.
Topics: Acyltransferases; Animals; Carcinoma, Squamous Cell; Enzyme Inhibitors; Gene Expression Profiling; Humans; Membrane Proteins; Mice; Neoplastic Stem Cells; Papillomaviridae; Papillomavirus Infections; Pyrazines; Pyridines; Skin Neoplasms; Stem Cell Niche; Wnt Proteins; Wnt Signaling Pathway | 2018 |
Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice.
Topics: Acyltransferases; Animals; Animals, Newborn; Bone and Bones; Bone Density; Cells, Cultured; Cortical Bone; Female; Femur; Flexural Strength; Membrane Proteins; Mice; Mice, Inbred C57BL; Osteoblasts; Pyrazines; Pyridines; Stress, Mechanical; Tibia | 2018 |
LGK974, a PORCUPINE inhibitor, mitigates cytotoxicity in an in vitro model of Parkinson's disease by interfering with the WNT/β-CATENIN pathway.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; beta Catenin; Cell Line; Cell Line, Tumor; Cell Survival; Glycogen Synthase Kinase 3; Humans; Immunohistochemistry; Paraquat; Parkinson Disease; Pyrazines; Pyridines; Wnt Signaling Pathway | 2018 |
Potent in vivo lung cancer Wnt signaling inhibition via cyclodextrin-LGK974 inclusion complexes.
Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclodextrins; Humans; Lung Neoplasms; Mice, Nude; Pyrazines; Pyridines; Wnt Proteins; Wnt Signaling Pathway | 2018 |
Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance.
Topics: Animals; Antineoplastic Agents; Cell Dedifferentiation; Cell Proliferation; Cells, Cultured; Colorectal Neoplasms; Drug Resistance, Neoplasm; Exosomes; Female; Fibroblasts; Fluorouracil; HT29 Cells; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Oxaliplatin; Paracrine Communication; Pyrazines; Pyridines; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2019 |
Discovery and structure-activity relationship study of phthalimide-phenylpyridine conjugate as inhibitor of Wnt pathway.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Molecular Structure; Pyrazines; Pyridines; Pyrimidinones; Signal Transduction; Structure-Activity Relationship; Wnt Signaling Pathway | 2019 |
Pharmacologic Inhibition of Porcupine, Disheveled, and β-Catenin in Wnt Signaling Pathway Ameliorates Diabetic Peripheral Neuropathy in Rats.
Topics: Animals; beta Catenin; Depsipeptides; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dishevelled Proteins; Enzyme Inhibitors; Male; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Wnt Signaling Pathway | 2019 |
Evaluation of antitumor effects of aspirin and LGK974 drugs on cellular signaling pathways, cell cycle and apoptosis in colorectal cancer cell lines compared to oxaliplatin drug.
Topics: Antineoplastic Agents; Apoptosis; Aspirin; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; MAP Kinase Signaling System; Oxaliplatin; Pyrazines; Pyridines; Wnt Signaling Pathway | 2020 |
WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Phenotype; Pyrazines; Pyridines; Wnt Proteins; Wnt Signaling Pathway | 2019 |
Pharmacological interventions targeting Wnt/β-catenin signaling pathway attenuate paclitaxel-induced peripheral neuropathy.
Topics: Animals; Behavior, Animal; Depsipeptides; Gene Expression Regulation; Male; Paclitaxel; Peripheral Nervous System Diseases; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Wnt Signaling Pathway | 2019 |
Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma.
Topics: Acyltransferases; Carcinoma, Renal Cell; Cell Line, Tumor; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Membrane Proteins; Neoplasm Proteins; Pyrazines; Pyridines; Wnt Signaling Pathway | 2020 |
WNT974 Inhibits Proliferation, Induces Apoptosis, and Enhances Chemosensitivity to Doxorubicin in Lymphoma Cells by Inhibiting Wnt/β-Catenin Signaling.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Lymphoma; Pyrazines; Pyridines; Wnt Signaling Pathway | 2020 |
EHMT2 epigenetically suppresses Wnt signaling and is a potential target in embryonal rhabdomyosarcoma.
Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Dimethyl Sulfoxide; Epigenesis, Genetic; Gene Expression Regulation, Developmental; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Mice; Mice, Nude; Puromycin; Pyrazines; Pyridines; Quinazolines; Rhabdomyosarcoma, Embryonal; RNA Interference; Wnt Signaling Pathway | 2020 |
LGK974 suppresses lipopolysaccharide-induced endotoxemia in mice by modulating the crosstalk between the Wnt/β-catenin and NF-κB pathways.
Topics: Animals; beta Catenin; Endotoxemia; Enzyme Inhibitors; Gene Expression Regulation; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pyrazines; Pyridines; Sepsis; Wnt1 Protein | 2021 |
Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Male; Mice; Mice, SCID; Neoplasms, Germ Cell and Embryonal; Pyrazines; Pyridines; Pyrimidinones; Testicular Neoplasms; Wnt Signaling Pathway | 2021 |
A molecular signature of well-differentiated oral squamous cell carcinoma reveals a resistance mechanism to metronomic chemotherapy and novel therapeutic candidates.
Topics: Administration, Metronomic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Drug Synergism; Female; Head and Neck Neoplasms; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Pyrazines; Pyridines; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Survival Rate; Tongue Neoplasms; Wnt Signaling Pathway; Young Adult | 2021 |
Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
Topics: Animals; Apc2 Subunit, Anaphase-Promoting Complex-Cyclosome; Artesunate; beta-Transducin Repeat-Containing Proteins; Cell Line, Tumor; Cullin Proteins; Glycogen Synthase Kinase 3 beta; Humans; Mice; Phosphatidylinositol 3-Kinases; Proteasome Endopeptidase Complex; Proteolysis; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins p21(ras); Pyrazines; Pyridines; TOR Serine-Threonine Kinases; Ubiquitin-Conjugating Enzymes; Ubiquitin-Protein Ligases; Ubiquitins; Wnt Signaling Pathway | 2022 |
The porcupine inhibitor WNT974 provokes ectodermal lineage differentiation of human embryonic stem cells.
Topics: Acyltransferases; Human Embryonic Stem Cells; Humans; Membrane Proteins; Pyrazines; Pyridines; Stearoyl-CoA Desaturase; Wnt Signaling Pathway | 2022 |
Model-based dose selection to inform translational clinical oncology development of WNT974, a first-in-class Porcupine inhibitor.
Topics: Antineoplastic Agents; Dose-Response Relationship, Drug; Humans; Maximum Tolerated Dose; Neoplasms; Pyrazines; Pyridines; Treatment Outcome | 2022 |
Mechanisms and inhibition of Porcupine-mediated Wnt acylation.
Topics: Acylation; Acyltransferases; Antineoplastic Agents; Binding Sites; Coenzyme A; Cryoelectron Microscopy; Histidine; Humans; Membrane Proteins; Neoplasms; Palmitoyl Coenzyme A; Pyrazines; Pyridines; Serine; Substrate Specificity; Wnt Signaling Pathway; Wnt3A Protein | 2022 |